standardmedia.co.ke

How to avoid hair breakage and hair loss when wearing weaves

For the best experience, please enable JavaScript in your browser settings. Wearing your protective style for too long actually damages your hair (Shutterstock ...
The American Journal of Managed Care

Long-Term Efficacy of Baricitinib for Severe Alopecia Areata

Researchers examined the impact of baricitinib withdrawal and retreatment on hair regrowth in patients with severe alopecia areata. Although baricitinib has demonstrated efficacy for treating patients ...
The American Journal of Managed Care

Baricitinib Shows Real-World Effectiveness in Severe Alopecia Areata Hair Loss

Baricitinib was generally well-tolerated. Acne was the most common adverse event (17.6%), followed by dyslipidemia (7.8%). Asthenia, elevated liver enzymes, and weight gain each occurred in fewer than ...
Healio

Topline data show upadacitinib improved severe alopecia

Please provide your email address to receive an email when new articles are posted on . Upadacitinib is an oral JAK inhibitor under investigation for the treatment of multiple dermatologic indications ...
Healio

FDA fast tracks rezpegaldesleukin for severe alopecia areata

Please provide your email address to receive an email when new articles are posted on . Rezpegaldesleukin is an interleukin-2 receptor pathway agonist that has shown success in other autoimmune ...
HealthDay on MSN

AAD: Baricitinib Efficacious for Hair Regrowth in Teens With Severe Alopecia Areata

TUESDAY, March 18, 2025 (HealthDay News) -- For adolescents with severe alopecia areata (AA), baricitinib is efficacious for ...
Medscape

FDA Puts Alopecia Treatment on Fast Track

The FDA has granted a “Fast Track” designation to rezpegaldesleukin (REZPEG) as a treatment for severe-to-very severe alopecia areata, according to a press release from the manufacturer, Nektar ...
Monthly Prescribing Reference

Leqselvi Approved for Severe Alopecia Areata

A greater proportion of patients treated with deuruxolitinib 8mg achieved a SALT score of less than or equal to 20 (80% or more scalp hair) compared with placebo. The Food and Drug Administration (FDA ...
MedPage Today

Third JAK Inhibitor for Alopecia Areata Wins FDA Approval

The FDA approved the oral Janus kinase (JAK) inhibitor deuruxolitinib (Leqselvi) to treat alopecia areata, drugmaker Sun Pharmaceutical announced on Thursday. The approval stipulates use of ...
Hosted on MSN

What’s New and Upcoming in Alopecia Areata Treatment?

Alopecia areata is an autoimmune skin condition that causes patches of hair loss on your scalp and other parts of your body with hair. Those can include the eyebrows, eyelashes, beard, and elsewhere.
abc27

Nektar Therapeutics Receives Fast Track Designation for Rezpegaldesleukin for the Treatment of Severe-to-Very Severe Alopecia Areata

SAN FRANCISCO, July 29, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for ...
AOL

Alopecia Universalis: What to Know About Complete Hair Loss

Alopecia universalis (AU) is a rare autoimmune condition that involves complete loss of hair on your face, scalp, and body. The earlier you seek treatment, the better your chances of maintaining your ...